Replies to post #3506 on AVEO Pharmaceuticals, Inc. (AVEO)

[Apophis]

Just waiting for sales numbers out of Europe and phase 3 tivozanib trial is now 2 months ahead of schedule.


300,000 potential clients just in Europe

$10 by years end and $20 in about 2 years.